Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Giacomin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 5, 2011
Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary preventionAnna Giacomin, Nora Cazzagon, Adriana Sergio, et al.
Digestive Diseases (Basel, Switzerland)|June 23, 2012
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challengesAnna Giacomin, Adriana Sergio, Veronica Vanin, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2010
Megestrol and embryonic extracts in the treatment of advanced hepatocellular carcinoma: A prospective randomized trial in the pre-sorafenib eraAnna Giacomin, Adriana Sergio, Veronica Vanin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 10, 2014
Sorafenib use in the transplant settingGiulia Castelli, Patrizia Burra, Anna Giacomin, et al.
Hepatology International|July 24, 2015
Circulating free DNA in the progression of liver damage to hepatocellular carcinomaMarika Piciocchi, Romilda Cardin, Alessandro Vitale, et al.
Journal of Gastroenterology and Hepatology|March 19, 2014
Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC)Caterina Pozzan, Romilda Cardin, Marika Piciocchi, et al.
The American Journal of Gastroenterology|January 8, 2008
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasivenessAdriana Sergio, Chiara Cristofori, Romilda Cardin, et al.
European Journal of Gastroenterology & Hepatology|May 26, 2009
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?Fabio Farinati, Adriana Sergio, Anna Giacomin, et al.
BMC Cancer|January 28, 2009
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center studyFabio Farinati, Adriana Sergio, Anna Baldan, et al.
Hepatology (Baltimore, Md.)|November 23, 2017
External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort studyMauro Borzio, Elena Dionigi, Angelo Rossini, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 5, 2011
Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary preventionAnna Giacomin, Nora Cazzagon, Adriana Sergio, et al.
Digestive Diseases (Basel, Switzerland)|June 23, 2012
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challengesAnna Giacomin, Adriana Sergio, Veronica Vanin, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2010
Megestrol and embryonic extracts in the treatment of advanced hepatocellular carcinoma: A prospective randomized trial in the pre-sorafenib eraAnna Giacomin, Adriana Sergio, Veronica Vanin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 10, 2014
Sorafenib use in the transplant settingGiulia Castelli, Patrizia Burra, Anna Giacomin, et al.
Hepatology International|July 24, 2015
Circulating free DNA in the progression of liver damage to hepatocellular carcinomaMarika Piciocchi, Romilda Cardin, Alessandro Vitale, et al.
Journal of Gastroenterology and Hepatology|March 19, 2014
Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC)Caterina Pozzan, Romilda Cardin, Marika Piciocchi, et al.
The American Journal of Gastroenterology|January 8, 2008
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasivenessAdriana Sergio, Chiara Cristofori, Romilda Cardin, et al.
European Journal of Gastroenterology & Hepatology|May 26, 2009
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?Fabio Farinati, Adriana Sergio, Anna Giacomin, et al.
BMC Cancer|January 28, 2009
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center studyFabio Farinati, Adriana Sergio, Anna Baldan, et al.
Hepatology (Baltimore, Md.)|November 23, 2017
External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort studyMauro Borzio, Elena Dionigi, Angelo Rossini, et al.
Pageof 2